Cell Separation Market Analysis Report By Product, By Cell Type, By Technique, By Application, By End Use, By Region And Segment Forecasts From 2021 To 2028

Report ID: MN17613133  |  Published: November 2021  |  No of Pages: 120
Format: Electronic (PDF)  |  Industry: Biotechnology


The global cell separation market was prized by USD 6.6 billion in 2020. It is estimated to witness 18.8% CAGR from 2021 to 2028.


The cell separation performs a significant function in a variety of applications, together with in-vitro diagnostics, therapeutic protein manufacture, biologics designing and development, plus the additional research functions.


The increasing commonness of communicable and chronic sicknesses, like Covid-19 as well as cancer plus incessant government plans, to make better the biotechnology business, are the most important pushing factors, adding to the enlargement of the market for cell separation.


Even though, cell separation apparatuses and linked products can provide precise as well as effectual outcomes and contain crucial functions in the subject of sickness analysis in addition to systematic investigate, but, elevated prices linked with these products are one of the most important reasons, hampering this market.

Besides, cell separation method includes a broad range of expenses relating to sera, reagents, services, kits and instruments. The reagents utilized for the particular functions are of elevated prices and cell separation system is costly. These factors are expected to restrict the expansion of the market, throughout the forecast period.

Effect of Covid-19

The Covid-19 pandemic has produced profitable openings for the researchers, to learn and recognize this new-fangled transmittable virus, to build up investigative tools and treatments for it. A number of biotech and pharmaceutical monsters have been carrying out fast as well as wide-ranging R&D actions to build up new testing kits, treatments, and vaccines. This has considerably increased the requirement for cell separation tools in research functions.

Application Insight

In 2020, the biomolecule isolation division held the maximum 30.8% revenue share and led the cell separation market. The rising concentration on the manufacture of biopharmaceuticals, together with recombinant proteins, monoclonal antibodies, and bio similar is the most leading issue adding to its maximum share. Rising financial support by the government, intended for fresh medicine development, furthermore, boosts the expansion of the market.

The cancer research and stem cell research divisions are anticipated to reveal rewarding augmentation, during the review phase. Increasing investment in cell sourced investigation by the research laboratories and companies is a crucial feature that can be added to the expansion of the division.

Technique Insight

The centrifugation sector retained the leading 42.7% revenue share and led the cell separation market, in 2020. This can be credited to the wide-ranging use of this method by biopharmaceutical as well as biotechnology companies, research laboratories and academic establishments.

The surface marker and filtration sectors are projected to observe considerable augmentation during the nearly prospect. Increasing funds by the companies in industrialized infrastructure plus the product progressions are the most important reasons, sustaining the expansion of this sector.

Cell Type Insight

The human cell section detained the major 44.8% revenue share and led the market, in 2020. Increasing concentration on cancer and human research along with wide-ranging functions of isolated human cells in biopharmaceuticals research, development, and clinical trials, is between the most important factors, adding to its principal share.

The animal cells section is expected to display a well-paid expansion speed for the period of the forecast. The rising concentration of healthcare, government, and private companies on fresh medicine finding as well as improvement is an input factor, directing the expansion of section.

Product Insight

The consumables division held the main 62.3% revenue share and led the global cell separation market, in 2020. This can be credited to frequent purchases of consumables. Increasing funds for R&D activities by biopharmaceutical and biotechnology companies, used for the improvement of superior biologics together with vaccines and monoclonal antibodies are, furthermore, powering the division. Therefore, the requirement for consumables is, moreover, projected to stay high, throughout the forecast period.

As a result of product development the instruments division is expected to show a profitable development rate, for the duration of the forecast. Technical progressions in instruments present well-organized cell separation in therapeutics, research, and diagnostics functions. Therefore, the business for instruments is projected to observe major expansion, throughout the forecast period. On the other hand, the elevated prices of instruments are likely to hold back the expansion of the market.

End Use Insight

In 2020, the research laboratories and institutes section held the biggest 43.9% revenue share of the cell separation market. It is projected to maintain its place right through the review period. This can be credited to rising R&D projects by research organizations, to build up new treatments in neuroscience and oncology. The rising figure of the research laboratories as well as institutes through the world is, moreover, expected to be the key driver of the section.


The biotechnology and biopharmaceutical companies section demonstrated momentous enlargement during the forecast period because of the rising R&D spending by these companies, meant for the occurrence of new products. These companies are in the process of wide-ranging R&D actions intended for the development of latest therapeutics that necessitate cell separation procedures.

Growing research actions by business associations, to build up competent vaccine as well as therapeutics intended for Covid-19, are expected to generate greater demand for cell separation resolutions, thus sustaining the development of the section.

Regional Insight

In 2020, North America detained the major 38.5% revenue share and led the global market for cell separation. This can be credited to the greater implementation of technically sophisticated solutions in the U.S. and deep-rooted biotech and pharmaceutical industries. Wide-ranging research actions via research universities in the subject of cell therapies have, furthermore, produced an enormous demand for the cell separation resolutions.

Besides, the excessive occurrences of infectious in addition to chronic sicknesses, together with the eruption of Covid-19, have produced growth in the requirement for the cell separation solutions, used for clinical along with research functions.

The market for the cell separation, in Asia Pacific is expected to observe major enlargement because of increasing biotechnology along with pharmaceutical industries in the nations like India and China. The growth in market penetration of key international companies and increase in healthcare spending in major nations of Asia Pacific are the factors, likely to impel the development of the sector, during the forecast period. Incessant research plans for gene and stem treatment in South Korea, Japan, and China have additionally increased the need for cell separation solutions, within the region.


The major companies are busy in inorganic as well as organic enlargement policies like mergers & acquisitions, partnerships, and new product development, to acquire greater share of the market.

Some of the companies for cell separation market are:

  • Merck KGaA
  • STEMCELL Technologies Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Terumo Corporation
  • Thermo Fisher Scientific, Inc.
  • Danaher
  • Cytiva
  • Beckman Coulter, Inc.

Report Scope

Report Attribute


Market size value in 2021

USD 7.7 billion

Revenue forecast in 2028

USD 25.8 billion

Growth Rate

CAGR of 18.8% from 2021 to 2028

Base year for estimation


Historical data

2016 - 2019

Forecast period

2021 - 2028

Quantitative units

Revenue in USD million and CAGR from 2021 to 2028

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product, cell type, technique, application, end use, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; Germany; U.K.; France; Italy; Spain; Russia; Japan; China; India; South Korea; Australia; Singapore; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE

Key companies profiled

Thermo Fisher Scientific, Inc.; Becton, Dickinson and Company; Danaher (Beckman Coulter, Inc.; Cytiva); Terumo Corporation; STEMCELL Technologies Inc.; Bio-Rad Laboratories, Inc.; Merck KGaA

Customization scope

Free report customization (equivalent to up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. 

Segments Covered in the Report

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Million Insights has segmented the global cell separation market report based on product, cell type, technique, application, end use, and region:

• Product Outlook (Revenue, USD Million, 2016 - 2028)
    • Consumables
        • Reagents, Kits, Media, and Sera
        • Beads
        • Disposables
    • Instruments
        • Centrifuges
        • Flow Cytometers
        • Filtration Systems
        • Magnetic-activated Cell Separator Systems

• Cell Type Outlook (Revenue, USD Million, 2016 - 2028)
    • Human Cells
    • Animal Cells

• Technique Outlook (Revenue, USD Million, 2016 - 2028)
    • Centrifugation
    • Surface Marker
    • Filtration

• Application Outlook (Revenue, USD Million, 2016 - 2028)
    • Biomolecule Isolation
    • Cancer Research
    • Stem Cell Research
    • Tissue Regeneration
    • In Vitro Diagnostics
    • Therapeutics

• End-use Outlook (Revenue, USD Million, 2016 - 2028)
    • Research Laboratories and Institutes
    • Hospitals and Diagnostic Laboratories
    • Cell Banks
    • Biotechnology and Biopharmaceutical Companies

• Regional Outlook (Revenue, USD Million, 2016 - 2028)
    • North America
        • U.S.
        • Canada
    • Europe
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
    • Asia Pacific
        • Japan
        • China
        • India
        • South Korea
        • Australia
        • Singapore
    • Latin America
        • Brazil
        • Mexico
        • Argentina
    • MEA
        • South Africa
        • Saudi Arabia
        • UAE

What questions do you have? Get quick response from our industry experts. Request More information
Key questions answered in the report include
key questions
We also offers customization on reports based on specific client requirement.
Request for Customization

Choose License Type

Research Assistance

Ryan Manuel
Ryan Manuel

Research Support Specialist, USA

  1. Phone: +1-408-610-2300
  2. Toll Free: +1-866-831-4085
  3. Email: [email protected]
Connect With Expert
  • World's largest premium report database
  • Transparent pre & post sale customer engagement model
  • Unparalleled flexibility in terms of rendering services
  • Safe & secure web experience
  • 24*5 Research support service

Get a Free Sample

FREE sample contains market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...